Professional Documents
Culture Documents
IRB Presentation
IRB Presentation
• Fifteen questions assess five domains of patient-reported health status: pain, physical comfort, physical
independence, psychological support, and emotional state
Objective
• To study and compare the quality recovery of patients undergoing Breast Conserving Therapy with Propofol
TCI and Sevoflurane as Inhalational agents using the QOR 15 questionnaire on 2 nd postoperative day
Methodology:
•STUDY DESIGN: Prospective Randomized controlled trial
•STUDY SETTING: Department of Anaesthesia, Shaukat Khanum Cancer Hospital and Research Centre,
Lahore. ,
• SAMPLE SIZE: A total of 74 patients included in this study divided into two groups (37 in each group,
inhalational sevoflurane and propofol TCI)
SAMPLING TECHNIQUE
• Consecutive sampling technique will be used
• All patients who meet the inclusion criteria will be randomly assigned to one of 2 groups using online
randomization software
• Our intervention is to use TCI of propofol to the assigned group for maintenance of anesthesia.
Risks and Benefits
• Patients receiving TCI of Propofol for maintenance have better recovery and propofol itself has antiemetic
properties so postoperative nausea and vomiting risk is further reduced
• Risks are the same as with Inhalational Sevoflurane which may include hypotension.
• Patient can be allergic to propofol as it contains emulsion that includes egg lecithin and soybean oil.
Consent and Budgeting
• Written informed consent will be taken.